Advertisement
Person › Details
Laure-Hélène Mercier (Innate Pharma S.A. (Euronext Paris: IPH, Nasdaq: IPHA))
Mercier, Laure-Hélène (Innate Pharma 201612 CFO– before EVP Finance before Head Investor Relations)
Organisation | Innate Pharma S.A. (Euronext Paris: IPH, Nasdaq: IPHA) | |
Product | cancer immunotherapy (immuno-oncology, I-O) | |
Product 2 | therapeutic antibody | |
Record changed: 2019-11-15 |
Advertisement
More documents for Laure-Hélène Mercier
- [1] Innate Pharma S.A.. (11/13/19). "Press Release: Innate Pharma Third Quarter 2019 Report"....
- [2] Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top